Historical snapshot from Q3 2023.View current holdings →
In Q3 2023, Driehaus Capital held 207 positions worth $4.8B. They initiated 43 new positions and exited 140. Their largest holding was CCJ ($154.8M). Portfolio value grew +7.4% versus the prior quarter.
Portfolio Value (13F)
$4.8B
Holdings
207
Top 10 Concentration
24.4%
QoQ Change
+7.4%
Turnover
14.7%
Sector Breakdown
Biotechnology96%(194)
Other Healthcare4%(13)
Q3 2023 Holdings (207)
| # | Ticker | Company | Change | Value | % of Portfolio | SI % Float ? |
|---|---|---|---|---|---|---|
| 1 | CCJ | Cameco Corp. | Decreased | $154.8M | 3.23% | — |
| 2 | XENE | Xenon Pharmaceuticals Inc. | Decreased | $154.2M | 3.22% | 6.3% |
| 3 | CRNX | Crinetics Pharmaceuticals Inc. | Decreased | $152.6M | 3.19% | 7.3% |
| 4 | IBN | Icici Bank Ltd. | Increased | $130.5M | 2.73% | 1.1% |
| 5 | GPCR | Structure Therapeutics Inc. | Increased | $120.4M | 2.52% | 14.5% |
| 6 | CELH | Celsius Holdings, Inc. | Increased | $112.5M | 2.35% | 12.4% |
| 7 | ATI | Ati Inc. | Held | $89.2M | 1.86% | 5.3% |
| 8 | CAMT | Camtek Ltd. | New | $87.9M | 1.84% | 8.7% |
| 9 | FTI | TechnipFMC plc | Increased | $84.5M | 1.77% | 3.5% |
| 10 | ELF | e.l.f. Beauty, Inc. | Decreased | $81.2M | 1.70% | 8.2% |
| 11 | TRPCF | Trip.com Group Ltd. | Increased | $80.2M | 1.68% | — |
| 12 | GTLS | Chart Industries Inc. | Increased | $79.4M | 1.66% | 10.9% |
| 13 | MNDY | monday.com Ltd. | Increased | $76.4M | 1.60% | 14.6% |
| 14 | FTAIN | FTAI Aviation Ltd. | Held | $73.6M | 1.54% | — |
| 15 | WT | WisdomTree, Inc. | Increased | $70.9M | 1.48% | 17.6% |
| 16 | SAIA | Saia Inc. | Decreased | $69.0M | 1.44% | 4.5% |
| 17 | BRBR | Bellring Brands, Inc. | Increased | $67.5M | 1.41% | 12.1% |
| 18 | PCVX | Vaxcyte Inc. | Increased | $67.5M | 1.41% | 11.7% |
| 19 | PCOR | Procore Technologies, Inc. | Increased | $62.2M | 1.30% | 15.2% |
| 20 | AXON | Axon Enterprise, Inc. | Decreased | $61.5M | 1.29% | 5.7% |
| 21 | NUVL | Nuvalent Inc. | Decreased | $57.0M | 1.19% | 6.2% |
| 22 | TDGMW | Tidewater Inc. | New | $56.0M | 1.17% | — |
| 23 | SITE | SiteOne Landscape Supply, Inc. | Held | $55.3M | 1.16% | 10.0% |
| 24 | TMDXOther Healthcare | TransMedics Group, Inc. | Decreased | $54.8M | 1.15% | 38.4% |
| 25 | MELI | Mercadolibre Inc. | Increased | $54.7M | 1.14% | 1.8% |
| 26 | APLD | Applied Digital Corp. | Increased | $53.6M | 1.12% | 20.5% |
| 27 | YUMC | Yum China Holdings, Inc. | Increased | $51.3M | 1.07% | 1.8% |
| 28 | ONTO | Onto Innovation Inc. | New | $48.4M | 1.01% | 7.7% |
| 29 | WSC | WillScot Holdings Corp. | Decreased | $45.3M | 0.95% | 12.2% |
| 30 | NE-WT | Noble Corp plc | New | $44.7M | 0.93% | — |
| 31 | SNPS | Synopsys Inc. | New | $44.6M | 0.93% | 2.6% |
| 32 | ENVX | Enovix Corp. | Increased | $43.6M | 0.91% | 27.1% |
| 33 | RELY | Remitly Global, Inc. | Increased | $40.8M | 0.85% | 10.0% |
| 34 | FIX | Comfort Systems Usa Inc. | Decreased | $38.9M | 0.81% | 2.8% |
| 35 | DUOL | Duolingo, Inc. | Increased | $38.0M | 0.79% | 20.4% |
| 36 | FSLY | Fastly, Inc. | Decreased | $37.8M | 0.79% | 15.5% |
| 37 | VC | Visteon Corp. | Decreased | $37.1M | 0.78% | 18.0% |
| 38 | GKOSOther Healthcare | Glaukos Corporation | Held | $36.8M | 0.77% | 7.9% |
| 39 | AGYS | Agilysys Inc. | Decreased | $35.4M | 0.74% | 7.4% |
| 40 | MOD | Modine Manufacturing CO | Increased | $34.4M | 0.72% | 6.0% |
| 41 | RMBS | Rambus Inc. | Held | $34.0M | 0.71% | 6.0% |
| 42 | GTLB | Gitlab Inc. | New | $33.0M | 0.69% | 8.3% |
| 43 | XPOF | Xponential Fitness, Inc. | Decreased | $33.0M | 0.69% | 50.2% |
| 44 | BAP | Credicorp Ltd. | Increased | $32.9M | 0.69% | 2.3% |
| 45 | ATECOther Healthcare | Alphatec Holdings, Inc. | Decreased | $32.8M | 0.68% | 10.5% |
| 46 | MDB | MongoDB, Inc. | Increased | $32.6M | 0.68% | 3.6% |
| 47 | INSPOther Healthcare | Inspire Medical Systems, Inc. | Decreased | $31.6M | 0.66% | 19.0% |
| 48 | NTRA | Natera Inc. | Increased | $31.6M | 0.66% | 4.5% |
| 49 | SPXC | SPX Technologies, Inc. | Increased | $31.1M | 0.65% | 4.2% |
| 50 | WFRD | Weatherford International plc | Increased | $30.6M | 0.64% | 6.6% |
| 51 | PWR | Quanta Services, Inc. | Decreased | $29.1M | 0.61% | 2.4% |
| 52 | EVR | Evercore Inc. | Increased | $29.0M | 0.61% | 3.2% |
| 53 | APGE | Apogee Therapeutics Inc. | New | $28.5M | 0.60% | 7.3% |
| 54 | SDRL | Seadrill Ltd. | New | $28.0M | 0.59% | 7.3% |
| 55 | ANET | Arista Networks, Inc. | Decreased | $27.7M | 0.58% | 1.1% |
| 56 | HDB | Hdfc Bank Ltd. | Decreased | $27.6M | 0.58% | 0.7% |
| 57 | RIG | Transocean Ltd. | New | $27.6M | 0.58% | 29.4% |
| 58 | DECK | Deckers Outdoor Corp. | Decreased | $27.4M | 0.57% | 9.7% |
| 59 | CRS | Carpenter Technology Corp. | Decreased | $27.3M | 0.57% | 3.0% |
| 60 | FICO | Fair Isaac Corp. | Held | $26.8M | 0.56% | 12.5% |
| 61 | STRL | Sterling Infrastructure, Inc. | Held | $26.7M | 0.56% | 4.4% |
| 62 | FN | Fabrinet | New | $26.7M | 0.56% | 6.1% |
| 63 | IBP | Installed Building Products, Inc. | Decreased | $25.9M | 0.54% | 7.9% |
| 64 | CLS | Celestica Inc. | New | $25.5M | 0.53% | 3.5% |
| 65 | TKO | TKO Group Holdings, Inc. | New | $25.1M | 0.52% | 11.3% |
| 66 | LSCC | Lattice Semiconductor Corp. | Held | $24.7M | 0.52% | 10.8% |
| 67 | GDEN | Golden Entertainment, Inc. | Decreased | $24.4M | 0.51% | 4.0% |
| 68 | AAON | Aaon, Inc. | Increased | $24.0M | 0.50% | 8.2% |
| 69 | DVAX | Dynavax Technologies Corporation | Increased | $24.0M | 0.50% | 13.2% |
| 70 | SOJF | Southern CO | Increased | $23.5M | 0.49% | — |
| 71 | KRYS | Krystal Biotech Inc. | Held | $23.0M | 0.48% | 19.2% |
| 72 | FRPT | Freshpet, Inc. | New | $22.3M | 0.47% | 19.4% |
| 73 | OSW | Onespaworld Holdings Ltd. | Increased | $22.3M | 0.47% | 7.0% |
| 74 | KNF | Knife River Corp. | Increased | $22.0M | 0.46% | 10.2% |
| 75 | HWM | Howmet Aerospace Inc. | Held | $22.0M | 0.46% | 2.6% |
| 76 | NBIX | Neurocrine Biosciences Inc. | Increased | $21.8M | 0.45% | 7.5% |
| 77 | ARLO | Arlo Technologies, Inc. | Increased | $21.6M | 0.45% | 13.7% |
| 78 | PRIM | Primoris Services Corp. | Held | $21.1M | 0.44% | 12.8% |
| 79 | TTI | Tetra Technologies Inc. | Increased | $20.1M | 0.42% | 8.0% |
| 80 | HURN | Huron Consulting Group Inc. | Held | $20.0M | 0.42% | 5.3% |
| 81 | HALO | Halozyme Therapeutics Inc. | Held | $19.9M | 0.42% | 17.7% |
| 82 | ESAB | Esab Corp. | Increased | $19.2M | 0.40% | 10.3% |
| 83 | UEC | Uranium Energy Corp. | Decreased | $19.1M | 0.40% | 14.8% |
| 84 | IDYA | IDEAYA Biosciences Inc. | Increased | $18.8M | 0.39% | 11.1% |
| 85 | CPA | Copa Holdings, S.A. | Decreased | $18.6M | 0.39% | 5.2% |
| 86 | LIN | Linde Plc | Increased | $18.4M | 0.38% | 1.3% |
| 87 | ARGX | argenx SE | Held | $17.9M | 0.37% | 2.2% |
| 88 | SMMT | Summit Therapeutics Inc. | Decreased | $17.8M | 0.37% | 26.3% |
| 89 | DT | Dynatrace, Inc. | Decreased | $17.7M | 0.37% | 5.7% |
| 90 | EMBJ | Embraer S.A. | Decreased | $17.6M | 0.37% | 1.1% |
| 91 | AXSM | Axsome Therapeutics Inc. | Held | $17.4M | 0.36% | 9.8% |
| 92 | GXO | GXO Logistics, Inc. | Increased | $17.3M | 0.36% | 7.3% |
| 93 | RXSTOther Healthcare | RxSight Inc. | Increased | $16.6M | 0.35% | 10.4% |
| 94 | FHN-PH | First Horizon Corp. | Increased | $16.5M | 0.35% | — |
| 95 | FRSH | Freshworks Inc. | New | $16.0M | 0.33% | 10.9% |
| 96 | IRWD | Ironwood Pharmaceuticals Inc. | Held | $15.3M | 0.32% | 10.3% |
| 97 | BLFY | Blue Foundry Bancorp | Increased | $13.9M | 0.29% | 3.8% |
| 98 | LEGN | Legend Biotech Corporation | New | $13.8M | 0.29% | 19.9% |
| 99 | LRN | Stride, Inc. | Decreased | $13.6M | 0.28% | 27.5% |
| 100 | GAMB | Gambling.com Group Ltd. | Increased | $13.1M | 0.27% | 4.5% |
| 101 | BMEA | Biomea Fusion Inc. | Decreased | $12.6M | 0.26% | 23.7% |
| 102 | ADMA | ADMA Biologics Inc. | Increased | $12.5M | 0.26% | 11.3% |
| 103 | SWTX | SpringWorks Therapeutics Inc. | Held | $12.4M | 0.26% | — |
| 104 | MTH | Meritage Homes Corp. | Held | $12.2M | 0.26% | 9.0% |
| 105 | VRT | Vertiv Holdings Co | New | $12.1M | 0.25% | 3.7% |
| 106 | GGAL | Grupo Financiero Galicia SA | Decreased | $12.0M | 0.25% | 18.9% |
| 107 | BLBD | Blue Bird Corp. | Held | $11.8M | 0.25% | 16.6% |
| 108 | SKWD | Skyward Specialty Insurance Group, Inc. | Increased | $11.8M | 0.25% | 4.8% |
| 109 | UUUU | Energy Fuels Inc. | Held | $11.6M | 0.24% | 21.4% |
| 110 | ARRY | Array Technologies, Inc. | New | $11.6M | 0.24% | 31.4% |
| 111 | HROW | Harrow, Inc. | Increased | $11.5M | 0.24% | 23.0% |
| 112 | CVNA | Carvana CO. | New | $11.1M | 0.23% | 12.6% |
| 113 | MUSA | Murphy USA Inc. | New | $11.1M | 0.23% | 5.0% |
| 114 | ATXS | Astria Therapeutics Inc. | Held | $10.8M | 0.23% | — |
| 115 | LECO | Lincoln Electric Holdings Inc. | Held | $10.6M | 0.22% | 2.5% |
| 116 | LPLA | LPL Financial Holdings Inc. | New | $10.3M | 0.22% | 2.5% |
| 117 | TEX | Terex Corp. | New | $10.1M | 0.21% | 7.1% |
| 118 | KALV | KalVista Pharmaceuticals, Inc. | Held | $10.0M | 0.21% | 14.4% |
| 119 | BLDR | Builders FirstSource, Inc. | Decreased | $9.8M | 0.21% | 10.2% |
| 120 | SYRE | Spyre Therapeutics, Inc. | Decreased | $9.8M | 0.21% | 15.4% |
| 121 | ABCM | Abcam plc | Decreased | $9.7M | 0.20% | — |
| 122 | HLMN | Hillman Solutions Corp. | $9.5M | 0.20% | 2.8% | |
| 123 | VCYT | Veracyte, Inc. | Held | $9.2M | 0.19% | 15.0% |
| 124 | HZNP | Horizon Therapeutics Public Ltd. | Decreased | $9.2M | 0.19% | — |
| 125 | W | Wayfair Inc. | New | $9.1M | 0.19% | 13.8% |
| 126 | VSOGF | Vista Energy, S.A.B. de C.V. | Increased | $9.1M | 0.19% | — |
| 127 | AMD | Advanced Micro Devices Inc. | New | $8.9M | 0.19% | 2.4% |
| 128 | NVT | nVent Electric plc | New | $8.8M | 0.18% | 3.4% |
| 129 | CAVA | Cava Group, Inc. | Increased | $8.8M | 0.18% | 14.4% |
| 130 | KNSA | Kiniksa Pharmaceuticals International, plc | New | $8.8M | 0.18% | 9.4% |
| 131 | PENOther Healthcare | Penumbra Inc. | Decreased | $8.4M | 0.17% | 6.6% |
| 132 | UPWK | Upwork, Inc. | New | $8.4M | 0.17% | 21.5% |
| 133 | TERN | Terns Pharmaceuticals Inc. | Held | $8.1M | 0.17% | 7.0% |
| 134 | CRDO | Credo Technology Group Holding Ltd. | Increased | $8.0M | 0.17% | 6.7% |
| 135 | PSMT | Pricesmart Inc. | Decreased | $7.9M | 0.17% | 9.7% |
| 136 | CPRI | Capri Holdings Ltd. | New | $7.9M | 0.17% | 12.8% |
| 137 | RARE | Ultragenyx Pharmaceutical Inc. | Decreased | $7.9M | 0.16% | 21.4% |
| 138 | PRCTOther Healthcare | PROCEPT BioRobotics Corp. | Held | $7.9M | 0.16% | 13.3% |
| 139 | GENI | Genius Sports Ltd. | New | $7.8M | 0.16% | 15.5% |
| 140 | IPSC | Century Therapeutics, Inc. | Decreased | $7.6M | 0.16% | 16.3% |
| 141 | TMCIOther Healthcare | Treace Medical Concepts, Inc. | Decreased | $7.5M | 0.16% | 3.8% |
| 142 | EG | Everest Group, Ltd. | New | $7.2M | 0.15% | 5.0% |
| 143 | EXAS | Exact Sciences Corporation | Decreased | $7.1M | 0.15% | 3.9% |
| 144 | LBRT | Liberty Energy Inc. | Increased | $7.0M | 0.15% | 14.9% |
| 145 | HLI | Houlihan Lokey, Inc. | New | $6.9M | 0.15% | 4.4% |
| 146 | BLD | TopBuild Corp. | Decreased | $6.9M | 0.14% | 8.3% |
| 147 | ALNY | Alnylam Pharmaceuticals Inc. | Held | $6.9M | 0.14% | 7.7% |
| 148 | APLS | Apellis Pharmaceuticals Inc. | Decreased | $6.9M | 0.14% | 12.6% |
| 149 | BZH | Beazer Homes Usa Inc. | New | $6.8M | 0.14% | 8.7% |
| 150 | TCMDOther Healthcare | Tactile Systems Technology Inc. | Increased | $6.8M | 0.14% | 12.8% |
| 151 | ETNB | 89bio Inc. | Held | $6.7M | 0.14% | — |
| 152 | LMATOther Healthcare | Lemaitre Vascular Inc. | Increased | $6.6M | 0.14% | 9.6% |
| 153 | RYTM | Rhythm Pharmaceuticals Inc. | Increased | $6.3M | 0.13% | 15.8% |
| 154 | RVMD | Revolution Medicines Inc. | Held | $6.0M | 0.13% | 5.9% |
| 155 | MGNI | Magnite, Inc. | Decreased | $6.0M | 0.13% | 8.6% |
| 156 | DAWN | Day One Biopharmaceuticals Inc. | Increased | $6.0M | 0.13% | 7.5% |
| 157 | NEO | Neogenomics Inc. | Held | $5.5M | 0.11% | 13.0% |
| 158 | NTNX | Nutanix, Inc. | New | $5.4M | 0.11% | 6.0% |
| 159 | HYAC-WT | Haymaker Acquisition Corp. 4 | New | $5.1M | 0.11% | — |
| 160 | TOST | Toast, Inc. | Decreased | $5.1M | 0.11% | 6.8% |
| 161 | RLAY | Relay Therapeutics Inc. | $5.0M | 0.10% | 24.8% | |
| 162 | OSK | Oshkosh Corp. | New | $4.8M | 0.10% | 3.9% |
| 163 | MLYS | Mineralys Therapeutics, Inc. | Held | $4.8M | 0.10% | 10.6% |
| 164 | ALKT | Alkami Technology, Inc. | New | $4.5M | 0.09% | 8.9% |
| 165 | NCLH | Norwegian Cruise Line Holdings Ltd. | Decreased | $4.5M | 0.09% | 23.9% |
| 166 | EVLVW | Evolv Technologies Holdings, Inc. | New | $4.0M | 0.08% | — |
| 167 | MSFT | Microsoft Corp. | Decreased | $3.2M | 0.07% | 0.8% |
| 168 | GLOB | Globant S.A. | Increased | $2.8M | 0.06% | 28.3% |
| 169 | LTH | Life Time Group Holdings, Inc. | New | $2.5M | 0.05% | 8.3% |
| 170 | CLYM | Climb Bio, Inc. | Held | $2.1M | 0.04% | 23.9% |
| 171 | AAPL | Apple Inc. | Decreased | $2.1M | 0.04% | 0.8% |
| 172 | TYRA | Tyra Biosciences, Inc. | $2.1M | 0.04% | 22.7% | |
| 173 | BRCB | Black Rock Coffee Bar, Inc. | $2.0M | 0.04% | 9.7% | |
| 174 | GOOG | Alphabet Inc. | Increased | $1.8M | 0.04% | — |
| 175 | FHTX | Foghorn Therapeutics Inc. | $1.7M | 0.04% | 6.6% | |
| 176 | UBER | Uber Technologies, Inc. | $1.6M | 0.03% | 2.5% | |
| 177 | MMYT | MakeMyTrip Ltd. | Increased | $1.5M | 0.03% | 14.2% |
| 178 | XOM | Exxon Mobil Corp. | $1.5M | 0.03% | 1.1% | |
| 179 | NVDA | Nvidia Corp. | Decreased | $1.4M | 0.03% | 1.3% |
| 180 | OLMA | Olema Pharmaceuticals, Inc. | $1.1M | 0.02% | 20.4% | |
| 181 | BHVN | Biohaven Pharmaceutical Holding | Decreased | $1.0M | 0.02% | 16.1% |
| 182 | VERA | Vera Therapeutics Inc. | $936K | 0.02% | 27.2% | |
| 183 | ORIC | ORIC Pharmaceuticals Inc. | New | $871K | 0.02% | 15.9% |
| 184 | AVGO | Broadcom Inc. | Increased | $815K | 0.02% | 1.2% |
| 185 | ARWR | Arrowhead Pharmaceuticals Inc. | Decreased | $792K | 0.02% | 10.6% |
| 186 | ROP | Roper Technologies Inc. | Increased | $733K | 0.02% | 5.3% |
| 187 | AZN | Astrazeneca Plc | Increased | $662K | 0.01% | 0.2% |
| 188 | UNHOther Healthcare | Unitedhealth Group Inc. | New | $661K | 0.01% | 2.0% |
| 189 | NOW | ServiceNow, Inc. | $635K | 0.01% | 2.9% | |
| 190 | BA-PA | Boeing CO | $595K | 0.01% | — | |
| 191 | VRTX | Vertex Pharmaceuticals Inc. | $587K | 0.01% | 2.0% | |
| 192 | NFLX | Netflix Inc. | Decreased | $546K | 0.01% | 2.0% |
| 193 | BSXOther Healthcare | Boston Scientific Corp. | Increased | $496K | 0.01% | 2.9% |
| 194 | GPN | Global Payments Inc. | New | $467K | 0.01% | 6.8% |
| 195 | GLPGF | Galapagos NV | $388K | 0.01% | — | |
| 196 | LLY | Eli Lilly & Co | Decreased | $324K | 0.01% | 0.8% |
| 197 | GM | General Motors Co | New | $293K | 0.01% | 2.3% |
| 198 | ETN | Eaton Corp plc | Decreased | $283K | 0.01% | 2.1% |
| 199 | AXP | American Express CO | Increased | $256K | 0.01% | 2.1% |
| 200 | MRK | Merck & Co., Inc. | Decreased | $240K | 0.01% | 1.1% |
| 201 | APOS | Apollo Global Management, Inc. | New | $237K | 0.00% | — |
| 202 | PLDGP | Prologis, Inc. | Decreased | $229K | 0.00% | — |
| 203 | SITM | Sitime Corp. | Increased | $215K | 0.00% | 7.5% |
| 204 | TMOOther Healthcare | Thermo Fisher Scientific Inc. | Increased | $210K | 0.00% | 1.5% |
| 205 | ANNX | Annexon Biosciences Inc. | Decreased | $208K | 0.00% | 17.9% |
| 206 | HST | Host Hotels & Resorts, Inc. | New | $194K | 0.00% | 8.1% |
| 207 | BTAI | BioXcel Therapeutics Inc. | $56K | 0.00% | 10.8% |
Top Movers This Quarter
Share changes reflect active decisions. Value changes include price moves.
Frequently asked questions
What stocks did Driehaus Capital own in Q3 2023?
Driehaus Capital held 207 biotech stocks in their 13F portfolio in Q3 2023. Their top positions include CCJ, XENE, CRNX, IBN, GPCR. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Driehaus Capital's portfolio worth in Q3 2023?
Driehaus Capital's tracked biotech portfolio was worth $4.8B across 207 positions, with total assets under management of approximately $28B. Portfolio values are based on 13F filings with the SEC.
What did Driehaus Capital buy in Q3 2023?
Driehaus Capital initiated 43 new positions in Q3 2023, including CAMT, TDGMW, ONTO, NE-WT, SNPS and 38 more. They also increased 74 existing positions.
What did Driehaus Capital sell in Q3 2023?
Driehaus Capital fully exited 140 positions in Q3 2023, including XPEL, WING, WCC, WNC, VTS and 135 more. They also trimmed 76 existing positions.
Is Driehaus Capital a biotech fund?
Growth-oriented investment firm founded by Richard Driehaus (d. 2021), now led by CEO Steve Weber. Michael Caldwell manages the healthcare/life sciences portfolio, applying growth-at-a-reasonable-price philosophy to biotech with a focus on companies with accelerating revenue growth and approaching commercial inflection points.
Want AI analysis, insider signals, and catalyst overlays for Driehaus Capital?
View latest Driehaus Capital portfolio →